Abstract:Hippocampal area CA2 is unique in many ways, largely based on the complement of genes expressed there. We, and other, have observed that CA2 neurons exhibit a uniquely robust tropism for adeno-associated viruses (AAVs) of multiple serotypes and variants. In this study, we aimed to systematically investigate the propensity for AAV tropism toward CA2 across a wide range of AAV serotypes and variants, injected either intrahippocampally or systemically, including AAV1, 2, 5, 6, 8, 9, DJ, PHP.B, PHP.eB, and CAP-B10. We found that most serotypes and variants produced disproportionally high expression of AAV-delivered genetic material in CA2, although two serotypes (AAV6 and DJ) did not. In an effort to understand the mechanism behind this observation, we considered perineuronal nets (PNNs) that ensheathe CA2 pyramidal cells and, among other functions, buffer diffusion of ions and molecules. We hypothesized that PNNs might attract AAV particles and maintain them in close proximity to CA2 neurons, thereby increasing exposure to AAV particles. However, genetic deletion of PNNs from CA2 did not decrease AAV transduction. Next, we next considered the AAV binding factors and receptors known to contribute to AAV transduction. We found that the AAV receptor (AAVR), which is critical to transduction, is abundantly expressed in CA2, and knockout of AAVR nearly abolished expression of AAV-delivered material by all serotypes tested. Additionally, we found CA2 enrichment of several cell-surface glycan receptors that AAV particles attach to before interacting with AAVR, including heparan sulfate proteoglycans, N-linked sialic acid and N-linked galactose. Indeed, CA2 showed the highest expression of AAVR and the investigated glycan receptors within the hippocampus. We conclude that CA2 neurons are endowed with multiple factors that make it highly susceptible to AAV transduction, particularly to the systemically available PHP variants, including CAP-B10. Given the curved structure of hippocampus and the relatively small size of CA2, systemic delivery of engineered PHP or CAP variants could all but eliminate the need for intrahippocampal AAV injections, particularly when injecting recombinase-dependent AAVs into animals expressing recombinases in CA2.

A new AAV tool for highly preferentially targeting hippocampal CA2

Specific AAV2/PHP.eB-mediated gene transduction of CA2 pyramidal cells via injection into the lateral ventricle

Hippocampal CA2 neurons disproportionately express AAV-delivered genetic cargo

AAV11 enables efficient retrograde targeting of projection neurons and enhances astrocyte-directed transduction

AAV9-Retro mediates efficient transduction with axon terminal absorption and blood–brain barrier transportation

AAV11 permits efficient retrograde targeting of projection neurons

An enhancer-AAV toolbox to target and manipulate distinct interneuron subtypes

A Novel Retrograde AAV Variant for Functional Manipulation of Cortical Projection Neurons in Mice and Monkeys

Develop an efficient and specific AAV-based labeling system for Muller glia in mice

The Glymphatic System Delivery Enhances the Transduction Efficiency of AAV1 to Brain Endothelial Cells in Adult Mice.

Intra-striatal AAV2.retro administration leads to extensive retrograde transport in the rhesus macaque brain: implications for disease modeling and therapeutic development

Selective transgene expression in cerebellar Purkinje cells and granule cells using adeno-associated viruses together with specific promoters

A mosaic adeno-associated virus vector as a versatile tool that exhibits high levels of transgene expression and neuron specificity in primate brain

Cre-dependent Adeno-Associated Virus Preparation and Delivery for Labeling Neurons in the Mouse Brain.

AAV-compatible optogenetic tools for activating endogenous calcium channels in vivo

Microglia-specific transduction via AAV11 armed with IBA1 promoter and miRNA-9 targeting sequences

Improving cell-specific recombination using AAV vectors in the murine CNS by capsid and expression cassette optimization

Expression-based selection identifies a microglia-tropic AAV capsid for direct and CSF routes of administration in mice

Functional analysis of mutations endowing rAAV2-retro with retrograde tracing capacity

Optimization of microRNA Target Sequence Arrangement in AAV Vectors Dramatically Enhances Specificity and Efficiency of Transgene Expression in Cortical Microglia

Stereotactic Delivery of Helper-dependent Adenoviral Viral Vectors at Distinct Developmental Time Points to Perform Age-dependent Molecular Manipulations of the Mouse Calyx of Held